Max Robotics — Global Service Robot Directory + US Certification

About

Andrew Metcalfe is a leading orthopaedic surgeon and researcher whose work is reshaping the landscape of joint replacement surgery. His primary focus is on the clinical and cost-effectiveness of robotic-assisted arthroplasty, specifically for total hip and knee replacements. Metcalfe’s major contribution lies in spearheading high-quality, pragmatic randomised controlled trials—such as the landmark RACER-knee and RACER-Hip studies—to rigorously evaluate whether the substantial costs of robotic-arm systems translate into meaningful improvements in surgical precision and patient outcomes. His research directly addresses the critical gap in evidence for these emerging technologies, moving beyond industry-sponsored claims to provide independent, robust data. With his most-cited paper, "Robotic trials in arthroplasty surgery" (2024), accumulating 22 citations, and his influential study protocols garnering over 20 citations collectively, Metcalfe’s work is already guiding clinical decision-making and healthcare policy. By challenging the assumption that technological advancement automatically equals better care, he is ensuring that future orthopaedic practice is both evidence-based and economically sustainable, ultimately aiming to reduce the number of dissatisfied patients after joint replacement.